ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
0.00%
Dow Jones
38,798.99
0.00%
US Dollar vs MXN
18.37077
0.22%
Brent Oil
80.365
1.29%
Bitcoin
69,418.31
-0.34%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
10/06/202407:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OSTKOverstock com Inc
10/06/202407:33Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyUSOTC:OGSRWOverseas Shipholding Group Inc (PK)
10/06/202407:33PR Newswire (US)Dancing Towards Wellness: The Synergy of Dance for PD® and Urban Poling Inc.'s Activator Poles
10/06/202407:33PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NCUTSX:NCUNevada Copper Corp
10/06/202407:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NNDMNano Dimension Ltd
10/06/202407:32GlobeNewswire Inc.Publication of an article in Nature's Scientific Reports describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases
10/06/202407:32PR Newswire (US)Red Clover HR Announces Strategic Partnership with Justworks
10/06/202407:32PR Newswire (US)Karma Wallet Appoints Former Visa Sustainability Chief Douglas Sabo as Strategic Advisor
10/06/202407:31Business WireCardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and ConfidentialityNASDAQ:CDIOCardio Diagnostics Holdings Inc
10/06/202407:31PR Newswire (US)3Degrees Launches Innovative Carbon Removal Suite for Streamlined Market Access
10/06/202407:31PR Newswire (Canada)La Banque Royale du Canada rachètera ses actions privilégiées de premier rang à dividende non cumulatif et à taux corrigé tous les cinq ans traitées en tant que FPUNV, série BBTSX:RYRoyal Bank of Canada
10/06/202407:30GlobeNewswire Inc.Sidetrade lance des fonctionnalités d'IA générative dédiées à l’Order-to-CashEU:ALBFRSideTrade
10/06/202407:30GlobeNewswire Inc.Sidetrade launches powerful Order-to-Cash Generative AI featuresEU:ALBFRSideTrade
10/06/202407:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONDSOndas Holdings Inc
10/06/202407:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTEKWMaris Tech Ltd
10/06/202407:30GlobeNewswire Inc.NewtekOne, Inc. CEO, Barry Sloane, to Attend the 25th Annual KBW Community Bank Investor Conference July 30-31, 2024NASDAQ:NEWTNewtekOne Inc
10/06/202407:30GlobeNewswire Inc.Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in MilanNASDAQ:SRZNSurrozen Inc
10/06/202407:30GlobeNewswire Inc.Presentation at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting Highlights Ashvattha Product Candidates for Neuroinflammation Imaging and Treatment
10/06/202407:30GlobeNewswire Inc.HF Foods Announces Settlement with SECNASDAQ:HFFGHF Foods Group Inc
10/06/202407:30Business WireMathWorks Unveils New 6G Exploration Library at IMS 2024 Conference
10/06/202407:30GlobeNewswire Inc.Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in BarcelonaNASDAQ:BDRXBiodexa Pharmaceuticals PLC
10/06/202407:30Business WireCoca-Cola Hellenic Bottling Company Selects CyberArk for Identity SecurityNASDAQ:CYBRCyberArk Software Ltd
10/06/202407:30Business WireMotorcar Parts of America Intends to Nominate Jack Liebau to Stand for Election to Its BoardNASDAQ:MPAAMotorcar Parts and Associates Inc
10/06/202407:30Business WireAlcoa Executive Vice President and Chief Financial Officer Molly Beerman to participate in JP Morgan 2024 Energy, Power & Renewables ConferenceNYSE:AAAlcoa Corporation
10/06/202407:30GlobeNewswire Inc.SRM Announces Custom Designed Product Order for In-(Movie)Theater MarketplaceNASDAQ:SRMSRM Entertainment Inc
10/06/202407:30Business WireColumbus McKinnon to Present at the Wells Fargo 2024 Industrials ConferenceNASDAQ:CMCOColumbus McKinnon Corporation
10/06/202407:30Business WireAsahi Kasei Achieves Technological Breakthrough With Innovative Electrolyte
10/06/202407:30GlobeNewswire Inc.LiveOne Provides Membership UpdateNASDAQ:LVOLiveOne Inc
10/06/202407:30GlobeNewswire Inc.SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage CompanyNASDAQ:ICUSeaStar Medical Holding Corporation
10/06/202407:30Business WireBlue Earth Diagnostics Highlights Results of Studies Evaluating Impact of Urinary Activity on Image Interpretation and Performance of POSLUMA® (Flotufolastat F 18) and 18F-Flotufolastat PET in Prostate Cancer

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
COIN
ETHUSD
Ethereum
FX
USDMXN
US Dollar vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
NYSE
BAC
Bank of America
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados